• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

GRIFOLS (GRF)

GRIFOLS S.A.
Change: 0.23 (2.82%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Address

c/Jesus i Maria, 6
Barcelona
ESP
08022

Telephone

+34 935712200

Website

https://www.grifols.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Grifols SA Fourth Quarter Earnings Results for 20252026-02-26T12:30:00
Grifols SA Fourth Quarter Earnings Conference Call for 20252026-02-26T12:30:00
Grifols SA Annual Report for 20252026-02-26T00:00:00
Grifols SA Third Quarter Earnings Conference Call for 20252025-11-07T18:30:00
Grifols SA Third Quarter Earnings Results for 20252025-11-07T00:00:00
Grifols SA Second Quarter Earnings Conference Call for 20252025-07-30T18:30:00
Grifols SA Second Quarter Earnings Results for 20252025-07-30T00:00:00
Grifols SA Annual General Meeting for 20252025-06-13T00:00:00
Grifols SA First Quarter Earnings Conference Call for 20252025-05-14T18:30:00
Grifols SA First Quarter Earnings Results for 20252025-05-14T00:00:00

Previous key dates

NameKey Date
Grifols SA First Quarter Earnings Conference Call for 20252025-05-14T18:30:00
Grifols SA First Quarter Earnings Results for 20252025-05-14T00:00:00
Grifols SA Fourth Quarter Earnings Conference Call for 20242025-02-26T12:30:00
Grifols SA Fourth Quarter Earnings Result for 20242025-02-26T00:00:00
Grifols SA Annual Report for 20242025-02-26T00:00:00
Grifols SA Third Quarter Earnings Conference Call for 20242024-11-08T18:30:00
Grifols SA Third Quarter Earnings Result for 20242024-11-08T00:00:00
Grifols SA Second Quarter Earnings Conference Call for 20242024-07-30T18:30:00
Grifols SA Second Quarter Earnings Result for 20242024-07-30T00:00:00
Grifols SA Annual General Meeting for 20242024-06-14T00:00:00
Grifols SA First Quarter Earnings Conference Call for 20242024-05-14T18:30:00
Grifols SA First Quarter Earnings Result for 20242024-05-14T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.